The emerging role of igg anti-high-density lipoproteins antibodies as novel biomarker for thrombotic arterial events in antiphospholipid syndrome patients

dc.contributor.author	Cecchi, Irene
dc.contributor.author	Radin, Massimo
dc.contributor.author	Rubini, Elena
dc.contributor.author	Suárez Díaz, Ana María
dc.contributor.author	Roccatello, Dario
dc.contributor.author	Sciascia, Savino
dc.contributor.author	Rodríguez Carrio, Javier
dc.date.accessioned	2019-11-14T10:22:35Z
dc.date.available	2019-11-14T10:22:35Z
dc.date.issued	2019
dc.identifier.issn	0003-4967
dc.identifier.issn	1468-2060
dc.identifier.uri	http://hdl.handle.net/10651/53420
dc.description	Annual European Congress of Rheumatology, EULAR (2019, Madrid)
dc.format.extent	p. 1421-1421
dc.language.iso	eng
dc.relation.ispartof	Annals Of The Rheumatic Diseases, 78(2)
dc.rights	© 2019 Cecchi et al.
dc.source	WOS:000472207104239
dc.title	The emerging role of igg anti-high-density lipoproteins antibodies as novel biomarker for thrombotic arterial events in antiphospholipid syndrome patients
dc.type	conference output	spa
dc.identifier.doi	10.1136/annrheumdis-2019-eular.4859
dc.relation.publisherversion	http://dx.doi.org/10.1136/annrheumdis-2019-eular.4859

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.